Combination of Thrombolysis and Glycoprotein IIb/IIIa Inhibition in Chronic Peripheral Thrombosis: A Case Report

• Váldodahkkit: Mubin I Syed (Dahkki), Ryan Gallagher (Dahkki), Zeshan Hussain (Dahkki), Azim Shaikh (Dahkki), Philip J Cain (Dahkki), Kamal Morar (Dahkki), Matthew Sebastian (Dahkki), Robert Tyrrell (Dahkki), Allen Guehl (Dahkki), Ronald Erdelyi (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: International Journal of Radiology and Radiation Oncology - Peertechz Publications, 2017-01-24.
• Fáttát: Case Report
• Liŋkkat: Connect to this object online.

<p>Currently, many interventionalists employ either tissue plasminogen activator (alteplase, Genentech,San Francisco, CA), or recombinant plasminogen activator (reteplase, Chiesi USA, Inc., Cary, NC), for peripheral thrombolysis. Further, combination therapy utilizing a thrombolytic agent and...